Alkermes’ Corporate Presentation to be Webcast at the Jefferies 2017 London Healthcare Conference
November 08 2017 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live at the Jefferies 2017 London
Healthcare Conference on Wednesday, Nov. 15, 2017 at 2:40 p.m. GMT
(9:40 a.m. ET). The presentation may be accessed under the
Investors tab on www.alkermes.com and will be archived for 14
days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171108006345/en/
Alkermes plcJennifer Zibuda, +1 781-609-6129Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2024 to May 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From May 2023 to May 2024